Skip NavigationSkip to Content
Return Return to Search Results

Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI

  1. Author:
    Turkbey, B.
    Xu, S.
    Kruecker, J.
    Locklin, J.
    Pang, Y. X.
    Shah, V.
    Bernardo, M.
    Baccala, A.
    Rastinehad, A.
    Benjamin, C.
    Merino, M. J.
    Wood, B. J.
    Choyke, P. L.
    Pinto, P. A.

  2. Author Address

    [Shah, V; Bernardo, M; Choyke, PL] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA. [Xu, S; Kruecker, J] Philips Res N Amer, Briarcliff Manor, NY USA. [Locklin, J; Wood, BJ] NCI, Ctr Intervent Oncol, Bethesda, MD 20892 USA. [Locklin, J; Wood, BJ] NIH, Ctr Clin, Bethesda, MD 20892 USA. [Pang, YX] Philips Healthcare, Cleveland, OH USA. [Shah, V; Bernardo, M] NCI Frederick, SAIC Frederick, Frederick, MD USA. [Baccala, A; Rastinehad, A; Benjamin, C; Pinto, PA] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA. [Merino, MJ] NCI, Lab Pathol, NIH, Bethesda, MD 20892 USA.;Choyke, PL (reprint author), NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA;pchoyke@mail.nih.gov
    1. Year: 2011
    2. Date: Mar
  2. Journal: Cancer Imaging
    1. 11
    2. 1
    3. Pages: 31-36
  4. Type of Article: Article
  5. ISSN: 1470-7330
  1. Abstract:

    During transrectal ultrasound (TRUS)-guided prostate biopsies, the actual location of the biopsy site is rarely documented. Here, we demonstrate the capability of TRUS-magnetic resonance imaging (MRI) image fusion to document the biopsy site and correlate biopsy results with multi-parametric MRI findings. Fifty consecutive patients (median age 61 years) with a median prostate-specific antigen (PSA) level of 5.8 ng/ml underwent 12-core TRUS-guided biopsy of the prostate. Pre-procedural T2-weighted magnetic resonance images were fused to TRUS. A disposable needle guide with miniature tracking sensors was attached to the TRUS probe to enable fusion with MRI. Real-time TRUS images during biopsy and the corresponding tracking information were recorded. Each biopsy site was superimposed onto the MRI. Each biopsy site was classified as positive or negative for cancer based on the results of each MRI sequence. Sensitivity, specificity, and receiver operating curve (ROC) area under the curve (AUC) values were calculated for multi-parametric MRI. Gleason scores for each multi-parametric MRI pattern were also evaluated. Six hundred and 5 systemic biopsy cores were analyzed in 50 patients, of whom 20 patients had 56 positive cores. MRI identified 34 of 56 positive cores. Overall, sensitivity, specificity, and ROC area values for multi-parametric MRI were 0.607, 0.727, 0.667, respectively. TRUS-MRI fusion after biopsy can be used to document the location of each biopsy site, which can then be correlated with MRI findings. Based on correlation with tracked biopsies, T2-weighted MRI and apparent diffusion coefficient maps derived from diffusion-weighted MRI are the most sensitive sequences, whereas the addition of delayed contrast enhancement MRI and three-dimensional magnetic resonance spectroscopy demonstrated higher specificity consistent with results obtained using radical prostatectomy specimens.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1102/1470-7330.2011.0007
  3. View record in Web of Science®
  4. WOS: 000295330200001

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel